Cognitive Behavioral Therapy (CBT) for Late Life Anxiety
NCT ID: NCT05380115
Last Updated: 2024-05-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2024-07-31
2025-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Telephone Psychotherapy for Late-Life Generalized Anxiety Disorder (GAD)
NCT01259596
Treatment of Late-life Anxiety in Primary Care Settings
NCT00938093
Cognitive Behavior Treatment of Older Adults With Generalized Anxiety Disorder in Primary Care
NCT00765219
Group Cognitive Behavioral Therapy for Insomnia in Older Adults
NCT03117777
Internet Delivered Cognitive Behavior Therapy Based on Intolerance of Uncertainty
NCT05820568
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CBT
All subjects enrolled received CBT for 10 weeks.
Cognitive Behavioral Therapy (CBT)
weekly one on one video or telephone interviews with a study coach
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cognitive Behavioral Therapy (CBT)
weekly one on one video or telephone interviews with a study coach
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* at least one of the following: any diagnosis of an anxiety or depressive disorder; anxiety, depression, or sleep disturbance as a symptom in the problem list or in the note; and use of anxiolytic, anti-depressant, and sleep aide medications.
Exclusion Criteria
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Wake Forest University Health Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gretchen Brenes, PhD
Role: PRINCIPAL_INVESTIGATOR
Atrium Health Wake Forest Baptist
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB00084483
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.